Andon Bio is building an early warning system for protein expression failure, making the supply and demand of translational resources visible for the first time at the molecular level
Andon Bio is building an early warning system for protein expression failure, making the supply and demand of translational resources visible for the first time at the molecular level. Using a nanopore sequencing method developed at the University of Colorado Anschutz Medical Campus, Andon directly measures tRNA charging — the molecular signal that reveals whether cells have the resources they need to efficiently produce proteins. This data powers a predictive engine that replaces guesswork with real measurements, helping companies improve protein yield and cut costly development cycles.
The unsolved need for protein yield optimization in synthetic biology manufacturing.
Utilizing nanopore sequencing technology to optimize protein yield in biotech manufacturing.
1 founders including Founder